Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

T. Rowe Price Associates Inc reported a 7.50% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Associates Inc reported a 7.50% stake in Monte Rosa Therapeutics, Inc., 4,637,060 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
7.50%
Shares
4,637,060
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.7.50%4,637,060

Source

View original at SEC

Related